Access cutting-edge ret-altered cancer treatment through this clinical trial at a research site in Stanford. Study-provided care at no cost to qualified participants.
Access ret-altered cancer specialists in Stanford at no cost
This study follows strict safety protocols and ethical guidelines
All study-related ret-altered cancer treatment provided free
The aim of this study is to assess the safety, side effects and effectiveness of EP0031 in patients with advanced RET-altered malignancies (NSCLC)
Sponsor: Ellipses Pharma
Check if you qualify for this ret-altered cancer clinical trial in Stanford, CA
If you're searching for ret-altered cancer treatment options in Stanford, CA, this clinical trial may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.
Our Stanford research site is actively enrolling participants for this clinical trial. You'll receive care from experienced ret-altered cancer specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.